Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF)

Area of Science:

• Neuro-oncology
• Immunology
• Cancer Stem Cell Biology

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor linked to cancer stem cells (CSCs).
• GBM actively suppresses the immune system to facilitate tumor growth.
• Progesterone-induced blocking factor (PIBF) is an immunomodulatory protein implicated in tumor-associated immune suppression.

Purpose of the Study:

• To investigate the expression of PIBF in GBM-derived cells.
• To explore PIBF's potential role in GBM's immune evasion strategies.

Main Methods:

• Isolation and in vitro culture of cells from six GBM samples.
• Characterization of cultured cells using markers for cancer stem cells.
• Assessment of PIBF expression via confocal microscopy, flow cytometry, ELISA, and real-time PCR.
• Quantification of interleukin 6 secretion.

Main Results:

• GBM-derived cells exhibited markers characteristic of cancer stem cells.
• Interleukin 6 was secreted by the cultured GBM cells.
• PIBF was consistently detected intracellularly in GBM-derived cells from all six samples, confirmed by three independent methods.

Conclusions:

• This study provides the first evidence of PIBF expression in cultured GBM-derived cells.
• PIBF represents a novel immunosuppressive factor utilized by GBM, contributing to immune escape.
• Understanding PIBF's role may open new therapeutic avenues for glioblastoma treatment.